首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
tenosynovial giant cell tumor (diffused type) 相关文献:
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL, Kawai A, Leithner A, Loong H, Mascard E, Morosi C, Otten N, Palmerini E, Patel SR, Reichardt P, Rubin B, Rutkowski P, Sangalli C, Schuster K, Seddon BM, Shkodra M, Staals EL, Tap W, van de Rijn M, van Langevelde K, Vanhoenacker FMM, Wagner A, Wiltink L, Stern S, Van de Sande VM, Bauer S.
Cancer Treat Rev. 2023 Jan;112:102491. doi: 10.1016/j.ctrv.2022.102491. Epub 2022 Dec 6.
PMID:36502615
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rüttinger D.
J Immunother Cancer. 2017 Jul 18;5(1):53. doi: 10.1186/s40425-017-0257-y.
PMID:28716061
Treatment updates on tenosynovial giant cell tumor.
Palmerini E, Staals EL.
Curr Opin Oncol. 2022 Jul 1;34(4):322-327. doi: 10.1097/CCO.0000000000000853.
PMID:35837703
Prospects of Treating Tenosynovial Giant Cell Tumor through Pexidartinib: A Review.
Alsayadi YMMA, Chawla PA.
Anticancer Agents Med Chem. 2021;21(12):1510-1519. doi: 10.2174/1871520620999201102123555.
PMID:33143617
Treatment Modalities for Refractory-Recurrent Tenosynovial Giant Cell Tumor (TGCT): An Update.
Dania V, Stavropoulos NA, Gavriil P, Trikoupis I, Koulouvaris P, Savvidou OD, Mavrogenis AF, Papagelopoulos PJ.
Medicina (Kaunas). 2024 Oct 12;60(10):1675. doi: 10.3390/medicina60101675.
PMID:39459462
Diffuse-Type Tenosynovial Giant Cell Tumor An Update of Current Management Strategies.
Naja A, Abboud A, Masrouha K, Ghert M, Saghieh S.
Bull Hosp Jt Dis (2013). 2024 Sep;82(3):178-185.
PMID:39150871
Single-Cell Analysis Clarifies Pathological Heterogeneity in Tenosynovial Giant Cell Tumor and Identifies Biomarkers for Predicting Disease Recurrence.
Xie Y, Chen C, Wu F, Peng Y, Su J, Zhao Y, Huang H, Li ZA, Pei Y, Li W, He Y, Xue T, Cao C, Peng S, Zhang X, Song W.
Adv Sci (Weinh). 2025 Jul;12(26):e2415835. doi: 10.1002/advs.202415835. Epub 2025 Mar 24.
PMID:40126353
Tenosynovial giant cell tumor: case report and review.
Lucas DR.
Arch Pathol Lab Med. 2012 Aug;136(8):901-6. doi: 10.5858/arpa.2012-0165-CR.
PMID:22849738
Intramuscular Tenosynovial Giant Cell Tumor, Diffuse-Type.
Lee YJ, Kang Y, Jung J, Kim S, Kim CH.
J Pathol Transl Med. 2016 Jul;50(4):306-8. doi: 10.4132/jptm.2015.11.15. Epub 2016 Jan 11.
PMID:26755356
Outcomes of Tenosynovial Giant Cell Tumor of the Foot and Ankle.
Barnett JR, Rudran B, Khan A, O'Reilly-Harbidge S, Patel S, Malhotra K, Cullen N, Welck M, Aston W.
Foot Ankle Int. 2023 Oct;44(10):1013-1020. doi: 10.1177/10711007231189491. Epub 2023 Aug 30.
PMID:37644900
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3